AHCO

SEC source: 0001104659-19-073991 · a4.xml · nonDerivative · entry 1

Connors Terence J · CIK 0001689279 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

SEC source: 0001104659-19-073994 · a4.xml · nonDerivative · entry 1

Weaver Susan T · CIK 0001687804 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

SEC source: 0001104659-19-073992 · a4.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

SEC source: 0001104659-19-073990 · a4.xml · nonDerivative · entry 1

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 301,250

SEC source: 0001104659-19-073989 · a4.xml · nonDerivative · entry 1

Parnes Josh · CIK 0001792687 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 228,125

SEC source: 0001104659-19-067180 · a4.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

SEC source: 0001104659-19-067181 · a4.xml · nonDerivative · entry 1

Rietkerk Shaw · CIK 0001792695 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,417

SEC source: 0001104659-19-067179 · a4.xml · nonDerivative · entry 1

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 296,250

SEC source: 0001104659-19-067178 · a4.xml · nonDerivative · entry 1

Parnes Josh · CIK 0001792687 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,125

SEC source: 0001193805-19-001431 · e619179_4-dfb.xml · derivative · entry 4

Flynn James E · CIK 0001352546 · Director · 10% owner · *Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Through Deerfield/RAB Ventures, LLC

Disclosed balance after: 1,640,981

Underlying: Common Stock · 460,685 shares

Expires not disclosed

F4 · kind: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, DRV LLC transferred to AdaptHealth and certain of its equityholders and employees shares of the Issuer's common stock and Private Placement Warrants, in each case, for no consideration. The numbers set forth in Column 4 of Table I and Columns 5 and 7 of Table II reflect the numbers of such transferred shares of common stock and Private Placement Warrants, as applicable, in respect of which, at the time of such transfer, Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC, and the numbers set forth in Column 5 of Table I and Column 9 of Table II reflect the numbers of shares of common stock and Private Placement Warrants held by DRV LLC following such transfer in which Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC.

F4 · shares: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, DRV LLC transferred to AdaptHealth and certain of its equityholders and employees shares of the Issuer's common stock and Private Placement Warrants, in each case, for no consideration. The numbers set forth in Column 4 of Table I and Columns 5 and 7 of Table II reflect the numbers of such transferred shares of common stock and Private Placement Warrants, as applicable, in respect of which, at the time of such transfer, Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC, and the numbers set forth in Column 5 of Table I and Column 9 of Table II reflect the numbers of shares of common stock and Private Placement Warrants held by DRV LLC following such transfer in which Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC.

F4 · price: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, DRV LLC transferred to AdaptHealth and certain of its equityholders and employees shares of the Issuer's common stock and Private Placement Warrants, in each case, for no consideration. The numbers set forth in Column 4 of Table I and Columns 5 and 7 of Table II reflect the numbers of such transferred shares of common stock and Private Placement Warrants, as applicable, in respect of which, at the time of such transfer, Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC, and the numbers set forth in Column 5 of Table I and Column 9 of Table II reflect the numbers of shares of common stock and Private Placement Warrants held by DRV LLC following such transfer in which Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC.

F7 · derivative.exercise_date: The Private Placement Warrants are substantially similar to the Public Warrants (see Footnote 9), except that, if held by the original holders or their permitted assigns, they (i) may be exercised on a cashless basis, (ii) are not subject to redemption and (iii) subject to certain limited exceptions, are subject to transfer restrictions until 30 days after the completion of the AdaptHealth Transaction. If the Private Placement Warrants are held by holders other than the initial purchaser or its permitted transferees, the Private Placement Warrants will be redeemable by the Issuer and exercisable by the holders on the same basis as the Public Warrants. The Private Placement Warrants expire five years after the completion of the AdaptHealth Transaction or earlier upon redemption or liquidation.

F7 · derivative.expiration_date: The Private Placement Warrants are substantially similar to the Public Warrants (see Footnote 9), except that, if held by the original holders or their permitted assigns, they (i) may be exercised on a cashless basis, (ii) are not subject to redemption and (iii) subject to certain limited exceptions, are subject to transfer restrictions until 30 days after the completion of the AdaptHealth Transaction. If the Private Placement Warrants are held by holders other than the initial purchaser or its permitted transferees, the Private Placement Warrants will be redeemable by the Issuer and exercisable by the holders on the same basis as the Public Warrants. The Private Placement Warrants expire five years after the completion of the AdaptHealth Transaction or earlier upon redemption or liquidation.

F4 · derivative.underlying_shares: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, DRV LLC transferred to AdaptHealth and certain of its equityholders and employees shares of the Issuer's common stock and Private Placement Warrants, in each case, for no consideration. The numbers set forth in Column 4 of Table I and Columns 5 and 7 of Table II reflect the numbers of such transferred shares of common stock and Private Placement Warrants, as applicable, in respect of which, at the time of such transfer, Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC, and the numbers set forth in Column 5 of Table I and Column 9 of Table II reflect the numbers of shares of common stock and Private Placement Warrants held by DRV LLC following such transfer in which Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC.

F4 · balance_after: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, DRV LLC transferred to AdaptHealth and certain of its equityholders and employees shares of the Issuer's common stock and Private Placement Warrants, in each case, for no consideration. The numbers set forth in Column 4 of Table I and Columns 5 and 7 of Table II reflect the numbers of such transferred shares of common stock and Private Placement Warrants, as applicable, in respect of which, at the time of such transfer, Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC, and the numbers set forth in Column 5 of Table I and Column 9 of Table II reflect the numbers of shares of common stock and Private Placement Warrants held by DRV LLC following such transfer in which Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC.

F2 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Private Design Fund IV is a member of Deerfield/RAB Ventures, LLC ("DRV LLC"), and is entitled to appoint one of the two members of DRV LLC's board of managers. Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV. Deerfield Management Company, L.P. ("Deerfield Management") is the investment manager of Deerfield Private Design Fund IV. James E. Flynn is the sole member of the general partner of each of Deerfield Management and Deerfield Mgmt IV, L.P.

F3 · ownership.nature: In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by Deerfield Private Design Fund IV or for the benefit of Deerfield Management, or in which Deerfield Private Design Fund IV has a pecuniary interest through DRV LLC, is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

SEC source: 0001193805-19-001431 · e619179_4-dfb.xml · nonDerivative · entry 3

Flynn James E · CIK 0001352546 · Director · 10% owner · *Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Through Deerfield Management Company, L.P.

Disclosed balance after: 20,000

F5 · kind: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, Steven Hochberg transferred to AdaptHealth and certain of its equityholders and employees shares of the Issuer's common stock for no consideration.

F5 · price: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, Steven Hochberg transferred to AdaptHealth and certain of its equityholders and employees shares of the Issuer's common stock for no consideration.

F2 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Private Design Fund IV is a member of Deerfield/RAB Ventures, LLC ("DRV LLC"), and is entitled to appoint one of the two members of DRV LLC's board of managers. Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV. Deerfield Management Company, L.P. ("Deerfield Management") is the investment manager of Deerfield Private Design Fund IV. James E. Flynn is the sole member of the general partner of each of Deerfield Management and Deerfield Mgmt IV, L.P.

F3 · ownership.nature: In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by Deerfield Private Design Fund IV or for the benefit of Deerfield Management, or in which Deerfield Private Design Fund IV has a pecuniary interest through DRV LLC, is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

F6 · ownership.nature: Steven Hochberg, a partner in Deerfield Management Company, served on the board of directors of the Issuer until the expiration of his term as a director immediately following the completion of the AdaptHealth Transaction. The common stock owned by Steven Hochberg and reported herein is held for the benefit, and at the direction, of Deerfield Management.

SEC source: 0001193805-19-001431 · e619179_4-dfb.xml · nonDerivative · entry 2

Flynn James E · CIK 0001352546 · Director · 10% owner · *Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Through Deerfield/RAB Ventures, LLC

Disclosed balance after: 2,279,888

F4 · kind: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, DRV LLC transferred to AdaptHealth and certain of its equityholders and employees shares of the Issuer's common stock and Private Placement Warrants, in each case, for no consideration. The numbers set forth in Column 4 of Table I and Columns 5 and 7 of Table II reflect the numbers of such transferred shares of common stock and Private Placement Warrants, as applicable, in respect of which, at the time of such transfer, Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC, and the numbers set forth in Column 5 of Table I and Column 9 of Table II reflect the numbers of shares of common stock and Private Placement Warrants held by DRV LLC following such transfer in which Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC.

F4 · shares: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, DRV LLC transferred to AdaptHealth and certain of its equityholders and employees shares of the Issuer's common stock and Private Placement Warrants, in each case, for no consideration. The numbers set forth in Column 4 of Table I and Columns 5 and 7 of Table II reflect the numbers of such transferred shares of common stock and Private Placement Warrants, as applicable, in respect of which, at the time of such transfer, Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC, and the numbers set forth in Column 5 of Table I and Column 9 of Table II reflect the numbers of shares of common stock and Private Placement Warrants held by DRV LLC following such transfer in which Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC.

F4 · price: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, DRV LLC transferred to AdaptHealth and certain of its equityholders and employees shares of the Issuer's common stock and Private Placement Warrants, in each case, for no consideration. The numbers set forth in Column 4 of Table I and Columns 5 and 7 of Table II reflect the numbers of such transferred shares of common stock and Private Placement Warrants, as applicable, in respect of which, at the time of such transfer, Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC, and the numbers set forth in Column 5 of Table I and Column 9 of Table II reflect the numbers of shares of common stock and Private Placement Warrants held by DRV LLC following such transfer in which Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC.

F4 · balance_after: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, DRV LLC transferred to AdaptHealth and certain of its equityholders and employees shares of the Issuer's common stock and Private Placement Warrants, in each case, for no consideration. The numbers set forth in Column 4 of Table I and Columns 5 and 7 of Table II reflect the numbers of such transferred shares of common stock and Private Placement Warrants, as applicable, in respect of which, at the time of such transfer, Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC, and the numbers set forth in Column 5 of Table I and Column 9 of Table II reflect the numbers of shares of common stock and Private Placement Warrants held by DRV LLC following such transfer in which Deerfield Private Design Fund IV had a pecuniary interest through its interest in DRV LLC.

F2 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Private Design Fund IV is a member of Deerfield/RAB Ventures, LLC ("DRV LLC"), and is entitled to appoint one of the two members of DRV LLC's board of managers. Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV. Deerfield Management Company, L.P. ("Deerfield Management") is the investment manager of Deerfield Private Design Fund IV. James E. Flynn is the sole member of the general partner of each of Deerfield Management and Deerfield Mgmt IV, L.P.

F3 · ownership.nature: In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by Deerfield Private Design Fund IV or for the benefit of Deerfield Management, or in which Deerfield Private Design Fund IV has a pecuniary interest through DRV LLC, is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

SEC source: 0001193805-19-001431 · e619179_4-dfb.xml · nonDerivative · entry 1

Flynn James E · CIK 0001352546 · Director · 10% owner · *Director by Deputization

Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization

Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Through Deerfield Private Design Fund IV, L.P.

Disclosed balance after: 14,900,000

F1 · kind: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination (the "AdaptHealth Transaction") with AdaptHealth Holdings, LLC ("AdaptHealth"), Deerfield Private Design Fund IV, L.P. ("Deerfield Private Design Fund IV") acquired from the Issuer 12,400,000 shares of common stock of the Issuer.

F2 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Private Design Fund IV is a member of Deerfield/RAB Ventures, LLC ("DRV LLC"), and is entitled to appoint one of the two members of DRV LLC's board of managers. Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV. Deerfield Management Company, L.P. ("Deerfield Management") is the investment manager of Deerfield Private Design Fund IV. James E. Flynn is the sole member of the general partner of each of Deerfield Management and Deerfield Mgmt IV, L.P.

F3 · ownership.nature: In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by Deerfield Private Design Fund IV or for the benefit of Deerfield Management, or in which Deerfield Private Design Fund IV has a pecuniary interest through DRV LLC, is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

SEC source: 0001104659-19-063570 · a4.xml · derivative · entry 2

BARASCH RICHARD A · CIK 0001076341 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,643,333

Underlying: Common Stock · 1,690,000 shares

Expires 2024-11-08

F1 · kind: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration.

F1 · price: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration.

F2 · ownership.nature: The shares are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.

SEC source: 0001104659-19-063570 · a4.xml · nonDerivative · entry 1

BARASCH RICHARD A · CIK 0001076341 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,672,500

F1 · kind: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration.

F1 · price: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration.

F2 · ownership.nature: The shares are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.

SEC source: 0001104659-19-063545 · a4.xml · derivative · entry 3

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 12,903

Underlying: Class A Common Stock · 12,903 shares

Expires not disclosed

F1 · kind: Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

F4 · derivative.exercise_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F4 · derivative.expiration_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F2 · ownership.nature: Securities held directly by Mayaid2001 LLC.

SEC source: 0001104659-19-063545 · a4.xml · derivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 266,331

Underlying: Class A Common Stock · 266,331 shares

Expires not disclosed

F3 · derivative.exercise_price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F3 · price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F3 · derivative.exercise_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F3 · derivative.expiration_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F2 · ownership.nature: Securities held directly by Mayaid2001 LLC.

SEC source: 0001104659-19-063545 · a4.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 70,315

F1 · kind: Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

F2 · ownership.nature: Securities held directly by Mayaid2001 LLC.

SEC source: 0001104659-19-063525 · a4.xml · derivative · entry 3

HOCHBERG STEVEN · CIK 0001034123 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,643,333

Underlying: Common Stock · 1,690,000 shares

Expires 2024-11-08

F3 · kind: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration.

F3 · price: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration.

F4 · ownership.nature: The securities are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.

SEC source: 0001104659-19-063525 · a4.xml · nonDerivative · entry 2

HOCHBERG STEVEN · CIK 0001034123 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,672,500

F3 · kind: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration.

F3 · price: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration.

F4 · ownership.nature: The securities are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.

SEC source: 0001104659-19-063525 · a4.xml · nonDerivative · entry 1

HOCHBERG STEVEN · CIK 0001034123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

F1 · kind: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, Steven Hochberg transferred to AdaptHealth Holdings, LLC and certain of its equityholders and employees shares of the Issuer's common stock for no consideration.

F2 · balance_after: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the securities for the benefit, and at the direction, of Deerfield Management Company, L.P.

SEC source: 0001104659-19-063529 · a4.xml · nonDerivative · entry 1

Weaver Susan T · CIK 0001687804 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

F1 · kind: Securities transferred by the reporting person to certain equityholders and employees of AdaptHealth Holdings LLC in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063544 · a4.xml · derivative · entry 3

Holst Gregg A · CIK 0001347931 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 33,348

Underlying: Class A Common Stock · 33,348 shares

Expires not disclosed

F1 · kind: Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

F4 · derivative.exercise_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F4 · derivative.expiration_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F2 · ownership.nature: Securities held directly by Wheatfield LLC.

SEC source: 0001104659-19-063544 · a4.xml · derivative · entry 2

Holst Gregg A · CIK 0001347931 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 688,334

Underlying: Class A Common Stock · 688,334 shares

Expires not disclosed

F3 · derivative.exercise_price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 354,988 of the common units of AdaptHealth Holdings LLC are subject to vesting, with 177,494 units vesting on May 17, 2020 and 88,747 units vesting on each of the first two anniversaries of such date.

F3 · price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 354,988 of the common units of AdaptHealth Holdings LLC are subject to vesting, with 177,494 units vesting on May 17, 2020 and 88,747 units vesting on each of the first two anniversaries of such date.

F3 · derivative.exercise_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 354,988 of the common units of AdaptHealth Holdings LLC are subject to vesting, with 177,494 units vesting on May 17, 2020 and 88,747 units vesting on each of the first two anniversaries of such date.

F3 · derivative.expiration_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 354,988 of the common units of AdaptHealth Holdings LLC are subject to vesting, with 177,494 units vesting on May 17, 2020 and 88,747 units vesting on each of the first two anniversaries of such date.

F2 · ownership.nature: Securities held directly by Wheatfield LLC.

SEC source: 0001104659-19-063544 · a4.xml · nonDerivative · entry 1

Holst Gregg A · CIK 0001347931 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 104,486

F1 · kind: Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

F2 · ownership.nature: Securities held directly by Wheatfield LLC.

SEC source: 0001104659-19-063530 · a4.xml · nonDerivative · entry 1

Wolfe Chris · CIK 0001472624 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

F1 · kind: Securities transferred by the reporting person to certain equityholders and employees of AdaptHealth Holdings LLC in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063526 · a4.xml · nonDerivative · entry 1

Kaushal Mohit · CIK 0001683021 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

F1 · kind: Securities transferred by the reporting person to certain equityholders and employees of AdaptHealth Holdings LLC in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063552 · a4.xml · derivative · entry 3

Rietkerk Shaw · CIK 0001792695 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,617

Underlying: Class A Common Stock · 11,617 shares

Expires not disclosed

F1 · kind: Securities transferred to the reporting person in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

F3 · derivative.exercise_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F3 · derivative.expiration_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

SEC source: 0001104659-19-063552 · a4.xml · derivative · entry 2

Rietkerk Shaw · CIK 0001792695 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,793

Underlying: Class A Common Stock · 239,793 shares

Expires not disclosed

F2 · derivative.exercise_price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019.

F2 · price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019.

F2 · derivative.exercise_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019.

F2 · derivative.expiration_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019.

SEC source: 0001104659-19-063552 · a4.xml · nonDerivative · entry 1

Rietkerk Shaw · CIK 0001792695 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,417

F1 · kind: Securities transferred to the reporting person in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063547 · a4.xml · nonDerivative · entry 1

Parnes Josh · CIK 0001792687 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,125

F1 · kind: Securities transferred to the reporting person in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063546 · a4.xml · derivative · entry 10

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 52,384

Underlying: Class A Common Stock · 52,384 shares

Expires not disclosed

F4 · kind: Securities held directly by LBM DBE Holdings LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

F6 · derivative.exercise_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F6 · derivative.expiration_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F4 · ownership.nature: Securities held directly by LBM DBE Holdings LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063546 · a4.xml · derivative · entry 9

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 93,212

Underlying: Class A Common Stock · 93,212 shares

Expires not disclosed

F3 · kind: Securities held directly by 2321 Capital LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

F6 · derivative.exercise_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F6 · derivative.expiration_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F3 · ownership.nature: Securities held directly by 2321 Capital LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063546 · a4.xml · derivative · entry 8

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 78,525

Underlying: Class A Common Stock · 78,525 shares

Expires not disclosed

F2 · kind: Securities held directly by Fresh Pond Investment LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

F6 · derivative.exercise_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F6 · derivative.expiration_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F2 · ownership.nature: Securities held directly by Fresh Pond Investment LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063546 · a4.xml · derivative · entry 7

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,081,249

Underlying: Class A Common Stock · 1,081,249 shares

Expires not disclosed

F5 · derivative.exercise_price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019.

F5 · price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019.

F5 · derivative.exercise_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019.

F5 · derivative.expiration_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019.

F4 · ownership.nature: Securities held directly by LBM DBE Holdings LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063546 · a4.xml · derivative · entry 6

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,923,964

Underlying: Class A Common Stock · 1,923,964 shares

Expires not disclosed

F5 · derivative.exercise_price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019.

F5 · price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019.

F5 · derivative.exercise_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019.

F5 · derivative.expiration_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019.

F3 · ownership.nature: Securities held directly by 2321 Capital LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063546 · a4.xml · derivative · entry 5

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,620,815

Underlying: Class A Common Stock · 1,620,815 shares

Expires not disclosed

F5 · derivative.exercise_price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019.

F5 · price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019.

F5 · derivative.exercise_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019.

F5 · derivative.expiration_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019.

F2 · ownership.nature: Securities held directly by Fresh Pond Investment LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063546 · a4.xml · nonDerivative · entry 4

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 87,551

F4 · kind: Securities held directly by LBM DBE Holdings LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

F4 · ownership.nature: Securities held directly by LBM DBE Holdings LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063546 · a4.xml · nonDerivative · entry 3

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 155,788

F3 · kind: Securities held directly by 2321 Capital LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

F3 · ownership.nature: Securities held directly by 2321 Capital LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063546 · a4.xml · nonDerivative · entry 2

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 131,241

F1 · kind: Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

F2 · ownership.nature: Securities held directly by Fresh Pond Investment LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063546 · a4.xml · nonDerivative · entry 1

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,250

F1 · kind: Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063528 · a4.xml · nonDerivative · entry 1

Sorensen Gregory · CIK 0001731883 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

F1 · kind: Securities transferred by the reporting person to certain equityholders and employees of AdaptHealth Holdings LLC in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.

SEC source: 0001104659-19-063327 · a4.xml · derivative · entry 2

Deerfield/RAB Ventures, LLC · CIK 0001731697 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,643,333

Underlying: Common Stock · 1,690,000 shares

Expires 2024-11-08

F1 · kind: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration.

F1 · price: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration.

SEC source: 0001104659-19-063327 · a4.xml · nonDerivative · entry 1

Deerfield/RAB Ventures, LLC · CIK 0001731697 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,672,500

F1 · kind: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration.

F1 · price: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration.

SEC source: 0001104659-18-022201 · a4.xml · nonDerivative · entry 1

BARASCH RICHARD A · CIK 0001076341 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 6,045,652

F1 · kind: 921,848 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376).

F1 · price: 921,848 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376).

F2 · ownership.nature: The shares are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.

SEC source: 0001104659-18-022203 · a4.xml · nonDerivative · entry 2

HOCHBERG STEVEN · CIK 0001034123 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 6,045,652

F3 · kind: 921,848 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's Registration Statement.

F3 · price: 921,848 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's Registration Statement.

F2 · balance_after: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the securities for the benefit, and at the direction, of Deerfield Management Company, L.P.

F4 · ownership.nature: The shares are held directly by Deerfield/RAB Ventures, LLC and indirectly by the Reporting Person, as manager of Deerfield/RAB Ventures, LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001104659-18-022203 · a4.xml · nonDerivative · entry 1

HOCHBERG STEVEN · CIK 0001034123 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,087

F1 · kind: 3,913 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376) (the "Registration Statement").

F1 · price: 3,913 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376) (the "Registration Statement").

F2 · balance_after: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the securities for the benefit, and at the direction, of Deerfield Management Company, L.P.

SEC source: 0001104659-18-022205 · a4.xml · nonDerivative · entry 1

Weaver Susan T · CIK 0001687804 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,087

F1 · kind: 3,913 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376).

F1 · price: 3,913 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376).

SEC source: 0001104659-18-022207 · a4.xml · nonDerivative · entry 1

Kaushal Mohit · CIK 0001683021 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,087

F1 · kind: 3,913 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376).

F1 · price: 3,913 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376).

SEC source: 0001104659-18-022206 · a4.xml · nonDerivative · entry 1

Sorensen Gregory · CIK 0001731883 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,087

F1 · kind: 3,913 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376).

F1 · price: 3,913 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376).